Along these lines, a bedside-to-bench approach using complementary techniques in SMN-deficient mouse models has recently confirmed and further characterized some of the biochemical alterations in SMA reported in this study [34]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.